QRISK3 | Framingham | ASCVD | PREDICTS |
Age | Age | Age | piHDL |
Sex | Sex | Sex | Leptin |
Ethnicity | Smoking status | Race | Homocysteine |
Diabetes | On blood pressure treatment | Diabetes | Soluble TWEAK |
Smoking status | Total cholesterol | Smoking status | Age ≥48 years |
Premature coronary artery disease in first-degree relative | HDL | On blood pressure treatment | Diabetes |
CKD (stage 3, 4 or 5) | Systolic blood pressure | Total cholesterol | |
Atrial fibrillation | LDL | ||
On blood pressure treatment | HDL | ||
Migraines | Systolic blood pressure | ||
Rheumatoid arthritis | Diastolic blood pressure | ||
SLE | On statin | ||
Severe mental illness | On aspirin | ||
On atypical antipsychotic | |||
On regular steroid tablets | |||
Erectile dysfunction | |||
Cholesterol to HDL ratio | |||
Systolic blood pressure | |||
SD of at least two most recent systolic blood pressure readings | |||
Body mass index |
ASCVD, Atherosclerotic Cardiovascular Disease; CKD, chronic kidney disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; piHDL, proinflammatory high-density lipoprotein; PREDICTS, Predictors of Risk for Elevated Flares, Damage Progression and Increased Cardiovascular Disease in Patients with SLE; TWEAK, tumor necrosis factor-like weak inducer of apoptosis.